Skip to content

Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases

Sensor-Based Analysis And rehabiLitation of bAlance in Neurological Diseases: a multiCentric randomizEd Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04874051
Acronym
BALANCE
Enrollment
120
Registered
2021-05-05
Start date
2019-09-02
Completion date
2023-12-31
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Parkinson Disease, Stroke

Keywords

Balance, Sensor-based rehabilitation, Virtual Reality

Brief summary

Balance impairment is one of the most common disorders due to a neurological diseases. Sensor-based technologies may be useful for falls prevention and balance recovery during patients hospitalization. OAK Elderly Care System (Khymeia Group, Noventa Padovana, Italy) allows the assessment of fall risk, the centre of pressure and the execution of balance exercises in a virtual environment.

Detailed description

The aim of the study is to compare the therapy provided by means of the OAK Elderly Care System with conventional physiotherapy for balance rehabilitation in patients affected by stroke, Multiple Sclerosis (MS) and Parkinson Disease (PD). OAK Elderly Care System consists of two independent balance boards and three sensors for the kinematic tracking of the trunk and lower limbs. These components allow the assessment of the centre of pressure and the execution of exercises in a virtual environment. 120 patients (40 stroke, 40 MS, 40 PK) hospitalized at 4 different italian hospitals, were enrolled according to inclusion and exclusion criteria and randomly assigned to two groups (i.e. intervention group, control group). Intervention group received 1 daily hour of technology-based treatment, while the control group underwent 1 daily hour of physiotherapy for balance rehabilitation, in addiction to 1 hour of conventional physiotherapy. Both treatments lasted 15 sessions. Before and after treatment balance, walking, daily living autonomy and pathology-specific features were assessed.

Interventions

DEVICEExperimental Group

The experimental treatment will be provided by means of the OAK system. This device consists of 1 cabinet with 2 independent balance boards, 2 monitors (one for the physiotherapist and one for the patient) and 3 wireless IMUs (one for the left lower limb, one for the right lower limb and one for the trunk). The 2 balance boards provide body weight transfer exercises, while the wireless motion sensors provide one leg stance exercises or trunk exercises in a virtual environment.

OTHERControl Group

The Control Group will perform conventional balance exercises similar to the exercises provided with the OAK system.

Sponsors

IRCCS San Raffaele
CollaboratorOTHER
Istituti Clinici Scientifici Maugeri SpA
CollaboratorOTHER
IRCCS National Neurological Institute C. Mondino Foundation
CollaboratorOTHER
I.R.C.C.S. Fondazione Santa Lucia
CollaboratorOTHER
IRCCS San Camillo, Venezia, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

The experimental group is treated through a sensor-based devices in a virtual environment, while the control group is treated through conventional physiotherapy for balance rehabilitation

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Common criteria: * Berg Balance Scale \< 50/56; * Ability to maintain the standing position with o without one support for 1 minute; * Functional Independence measure \< 100/126; * Barthel Index \< 80/100. Stroke: * Single ischemic stroke; * Lesion occured after 2 and within 18 months; * National Institute of Health Stroke Scale ≤ 14. Parkinson: * 1.5 \< Hoehn & Yahr \< 3; * Subitem freezing when walkingof the UPDRS ≤ 2. Multiple Sclerosis: * Relapsing remitting or secondary progressive Multiple Sclerosis; * Expanded Disability Status Scale ≤ 6.5.

Exclusion criteria

* Untreated epilepsy; * Major depressive disorder; * Fractures; * Dementia; * Ideomotor Apraxia; * Neglect; * Severe impairment of verbal comprehension; * Severe acoustic and visual disorders.

Design outcomes

Primary

MeasureTime frameDescription
Berg Balance Scale (BBS)Change from baseline Berg Balance Scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means better outcome (minimum score = 0, maximum score = 56).

Secondary

MeasureTime frameDescription
Number of falls during the last yearChange from baseline number of falls during the last year scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions).
Functional Ambulation Classification (FAC)Change from baseline Functional Ambulation Classification at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means better outcome (minimum score = 0, maximum score = 5).
Activities specific-Balance Confidence scale (ABC)Change from baseline Activities specific-Balance Confidence scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means better outcome (minimum score = 0, maximum score = 100).
Functional Independence Measure (FIM)Change from baseline Functional Independence Measure at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means better outcome (minimum score = 0, maximum score = 126).
National Institution of Health Stroke Scale (NIHSS)Change from baseline National Institute of Health Stroke Scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means worse outcome (minimum score = 0, maximum score = 42).
Unified Parkinson's Disease Rating Scale (UPDRS)Change from baseline Unified Parkinson's Disease Rating Scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means worse outcome (minimum score = 0, maximum score = 147).
Hoehn & Yahr Scale (H&Y)Change from baseline Hoehn & Yahr Scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means worse outcome (minimum score = 0, maximum score = 5).
Kurtzke Extended Disability Status Scale (EDSS)Change from baseline Kurtzke Extended Disability Status Scale at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means worse outcome (minimum score = 0, maximum score = 10).
Barthel Index (BI)Change from baseline Barthel Index at the end of the therapy (three weeks thereafter)Applied at the beginning and at the end of treatment (after 15 sessions). A higher score means better outcome (minimum score = 0, maximum score = 100).

Other

MeasureTime frameDescription
Instrumental assessmentChange from baseline BBS at the end of the therapy (three weeks thereafter)The OAK system will record the changes of the center of pressure during 30 seconds, with relaxed arms and eyes open.

Countries

Italy

Contacts

Primary ContactAndrea Turolla, PhD
andrea.turolla@ospedalesancamillo.net00390412207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026